These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23083672)

  • 1. Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Teraki Y; Kawabe M; Izaki S
    J Allergy Clin Immunol; 2013 Mar; 131(3):907-9. PubMed ID: 23083672
    [No Abstract]   [Full Text] [Related]  

  • 2. Disturbed balance in three subpopulations of CD4(+)Foxp3(+) regulatory T cells in Stevens-Johnson syndrome and toxic epidermal necrolysis patients.
    Yoshioka N; Suto A; Abe R; Saito N; Murata J; Hayashi-Ujiie I; Hoshina D; Fujita Y; Shimizu H
    Clin Immunol; 2013 Jul; 148(1):89-91. PubMed ID: 23665550
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel mechanism for therapeutic action of IVIg in autoimmune blistering dermatoses.
    Michael D; Grando SA
    Curr Dir Autoimmun; 2008; 10():333-43. PubMed ID: 18460894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions.
    Hirahara K; Kano Y; Mitsuyama Y; Takahashi R; Kimishima M; Shiohara T
    Clin Exp Dermatol; 2010 Dec; 35(8):863-8. PubMed ID: 20456395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Chronopoulos A; Pleyer U; Mockenhaupt M
    Klin Monbl Augenheilkd; 2012 May; 229(5):534-9. PubMed ID: 22592345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-13 levels are increased in patients with Stevens-Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme.
    Quaglino P; Caproni M; Osella-Abate S; Torchia D; Comessatti A; Del Bianco E; Antiga E; Frezzolini A; Schena D; Marzano A; De Simone C; Parodi A; Fabbri P; Bernengo MG
    Br J Dermatol; 2008 Jan; 158(1):184-6. PubMed ID: 17941938
    [No Abstract]   [Full Text] [Related]  

  • 9. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers.
    Hirahara K; Kano Y; Sato Y; Horie C; Okazaki A; Ishida T; Aoyama Y; Shiohara T
    J Am Acad Dermatol; 2013 Sep; 69(3):496-8. PubMed ID: 23957982
    [No Abstract]   [Full Text] [Related]  

  • 11. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
    J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxyfylline in toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Sanclemente G; De la Roche CA; Escobar CE; Falabella R
    Int J Dermatol; 1999 Nov; 38(11):878-9. PubMed ID: 10583942
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome of Stevens Johnson syndrome and toxic epidermal necrolysis treated with corticosteroids.
    Rijal A; Agrawal S
    Indian J Dermatol Venereol Leprol; 2009; 75(6):613-4. PubMed ID: 19915248
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic and local management at the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
    Sotozono C; Ueta M; Kinoshita S
    Am J Ophthalmol; 2010 Feb; 149(2):354; author reply 355. PubMed ID: 20103059
    [No Abstract]   [Full Text] [Related]  

  • 15. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
    Teo L; Tay YK; Liu TT; Kwok C
    Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of toxic epidermal necrolysis/Stevens-Johnson syndrome overlap with human granulocyte colony stimulating factor: a case report.
    Pallesen KA; Robinson S; Toft P; Andersen KE
    Acta Derm Venereol; 2012 Mar; 92(2):212-3. PubMed ID: 22068367
    [No Abstract]   [Full Text] [Related]  

  • 17. IVIG for the treatment of toxic epidermal necrolysis.
    Mittmann N; Chan BC; Knowles S; Shear NH
    Skin Therapy Lett; 2007 Feb; 12(1):7-9. PubMed ID: 17361314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe cutaneous adverse reactions to drugs.
    Chia FL; Leong KP
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Mockenhaupt M
    Expert Rev Clin Immunol; 2011 Nov; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.